Effectiveness and safety of a glutaraldehyde-modified, L-tyrosine-adsorbed and monophosphoryl lipid A-Adjuvanted allergen immunotherapy in patients with allergic asthma sensitized to olive pollen: A retrospective, controlled real-world study.
World Allergy Organ J
; 13(12): 100487, 2020 Dec.
Article
em En
| MEDLINE
| ID: mdl-33376572
AAAAI, American Academy of Allergy, Asthma & Immunology; AIT, allergen immunotherapy; ARIA, Allergic Rhinitis and its Impact on Asthma; ARs, adverse reactions; Allergen immunotherapy; Allergic asthma; Allergic rhinitis; Allergoid; EAACI, European Academy of Allergy and Clinical Immunology; GEMA, "Guía Española para el Manejo del Asma" (Spanish Guidelines for Asthma Management); GINA, Global Initiative for Asthma; LABAs, long-acting beta-2 agonists; LTRAs, leukotriene receptor antagonists; MCT, microcrystalline tyrosine; MPL, monophosphoryl lipid A; Microcrystalline tyrosine; Monophosphoryl lipid A; Olive pollen; SABAs, short-acting beta-agonists; SCIT, subcutaneous immunotherapy; Subcutaneous immunotherapy
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article